Timpe; Carsten

Patent Applications and Registrations

Patent applications and USPTO patent grants for Timpe; Carsten.The latest application filed is for "choline salt of an anti-inflammatory substituted cyclobutenedione compound".

Company Profile

0.7.5

Timpe; Carsten - Neuenberg DE
Timpe; Carsten - Basel CH
Timpe; Carsten - Hamburg DE
Timpe; Carsten - Weissenborn DE
Timpe; Carsten - Wessenborn DE
Timpe; Carsten - Apolda DE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Choline salt of an anti-inflammatory substituted cyclobutenedione compound Grant 9,018,261 - Ambarkhane , et al. April 28, 2	2015-04-28
Choline Salt Of An Anti-inflammatory Substituted Cyclobutenedione Compound App 20140206768 - Ambarkhane; Ameet Vijay ; et al.	2014-07-24
Solid Dispersion Of A Neurokinin Antagonist App 20100015225 - Diederich; Anke ; et al.	2010-01-21
Crystalline forms of {2-[1-(3,5-bis-trifluoromethyl-benzyl)-5-pyridin-4-yl-1H-[1,2,3]triazol-4- -yl]-pyridin-3-yl}-(2-chlorophenyl)-methanone Grant 7,381,826 - Borghese , et al. June 3, 2	2008-06-03
Novel crystalline forms of {2-[1-(3,5-bis-trifluoromethyl-benzyl)-5-pyridin-4-yl-1h-[1,2,3] triazol-4-yl]-pyridin-3-yl}-(2-chlorophenyl)-methanone App 20070078166 - Borghese; Alfio ; et al.	2007-04-05
Bioadhesive tablet containing testosterone/testosterone ester mixtures and method for producing a predetermined testosterone time-release profile with same Grant 6,977,083 - Huebler , et al. December 20, 2	2005-12-20
Homogeneous preformulations containing high concentration of steroids, for producing low-dose solid and semi-solid pharmaceutical preparations App 20020119103 - Grawe, Detlef ; et al.	2002-08-29
Method of making a perorally administered solid drug with controlled effective ingredient delivery Grant 6,117,450 - Dittgen , et al. September 12, 2	2000-09-12
Bioadhesive tablet Grant 6,063,404 - Timpe , et al. May 16, 2	2000-05-16
Compound preparation for the treatment of hypogonadal men and men with hypophyseal diseases Grant 5,855,905 - Oettel , et al. January 5, 1	1999-01-05

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.